MAPK9 and hepatocellular carcinoma: Compound deficiency of JNK1 and JNK2 indicate that JNK plays a duel role (i.e., tumor promoting and suppressing) in the development of hepatocellular carcinoma (HCC), which is cell type dependent (Das et al., 2011; Wu et al., 2019).